BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Aradigm Corporation

Aradigm is engaged in the development of novel pulmonary drug delivery systems designed to enhance the delivery and effectiveness of a number of existing development-stage drugs and reduce the need for injectable drug delivery. Aradigm's principal product development programs are based on its AERx(TM) Pulmonary Drug Delivery System, which uses proprietary technologies to create aerosols from liquid drug formulations for delivery locally to the lung or systemically via the lung. The Company believes that its systems can potentially be used to deliver a number of existing drugs for a variety ofapplications and may also offer a promising means of delivery for many new drugs being developed by pharmaceutical and biotechnology companies.


Contact Details:
3929 Point Eden Way
Hayward
CA
94545
United States of America
Tel:510 265 9000
Fax:510 265 0277
Email:
WWW:

www.aradigm.com/




Loading...

Recent Publications by Aradigm Corporation:

The effects of system parameters on in vivo injection performance of a needle-free injector in human volunteers.
PURPOSE: For a novel needle-free injection (NFI) system, the relationship...
5th September, 2007
Aradigm Corporation, Hayward, California, USA. Pharm Res. 2007 Aug;24(8):1501-7. Epub 2007 Mar 23.
DOI Direct Link
Pulmonary delivery of opioids as pain therapeutics.
Pulmonary opioid delivery, on the basis of the fact that small molecular...
18th January, 2007
Aradigm Corporation, Adv Drug Deliv Rev. 2006 Oct 31;58(9-10):1076-88. Epub 2006 Aug 12.
DOI Direct Link
Gamma scintigraphic evaluation of a miniaturized AERx pulmonary delivery system for aerosol delivery to anesthetized animals using a positive pressure ventilation system.
The purpose of this study was to characterize performance of a...
6th May, 2005
Aradigm Corporation, J Aerosol Med. 2005 Spring;18(1):34-44.
DOI Direct Link
Effect of gender and device mouthpiece shape on bolus insulin aerosol delivery using the AERx pulmonary delivery system.
PURPOSE: A study was designed to compare differences in insulin aerosol...
2nd March, 2005
Aradigm Corporation, Pharm Res. 2004 Oct;21(10):1776-82.
Safety and pharmacokinetics of inhaled morphine delivered using the AERx system in patients with moderate-to-severe asthma.
OBJECTIVE: The safety and pharmacokinetics of inhaled morphine in...
13th November, 2004
Aradigm Corporation, Int J Clin Pharmacol Ther. 2004 Aug;42(8):456-62.

View more Aradigm Corporation research publications.

BioNews Results for Aradigm Corporation:

Aradigm Announces Second Quarter 2008 Financial Results
DiGiTAL50:  Aug 13 2008 11:59AM Matching: aradigm
Aradigm Announces Second Quarter 2008 Financial Results
SmartBrief:  Aug 9 2008 11:17AM Matching: aradigm
Aradigm Announces Second Quarter 2008 Financial Results
Genetic Engineering News:  Aug 8 2008 11:51AM Matching: aradigm
Aradigm loses $7.1M in Q2
East Bay Business Journal:  Aug 8 2008 5:43PM Matching: aradigm
Aradigm's Q2 loss grows
Business Journal of Milwaukee:  Aug 8 2008 6:27PM Matching: aradigm
Promote your company here: BioNewsCast - Press Release Distribution

View more Aradigm Corporation news.

Aradigm Corporation Patents:

US Patent No.Title
6098615 Method of reproducibly effecting a patient's glucose level
6351984 Inspection method and device for non-destructive analysis of a container material
6354516 Pore structures for reduced pressure aerosolization
6369354 Excimer laser ablation process control of multilaminate materials
6408854 Insulin delivery enhanced by coached breathing

View more Aradigm Corporation patents.

Aradigm Corporation (ARDM) Financial information Links from Barchart

ARDM Quote from from Barchart.com
ARDM Chart from from Barchart.com
ARDM Profile from from Barchart.com
ARDM Opinion from from Barchart.com

View more Aradigm Corporation finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 179 times since April 2007, the link to the organisation's website has been followed 39 times

Recent Search Terms used to find this page: aradigm | Aradigm Corporation | t | Aradigm EXCIMER LASER AERx | .

Search for more companies in Hayward

Search for more companies in CA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Aradigm Corporation
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.